5,6-dihydroxyindole-2-carboxylic acid oxidase (277-297)

5,6-dihydroxyindole-2-carboxylic acid oxidase (277-297) is a synthetic peptide fragment corresponding to residues 277 to 297 of the oxidase enzyme that acts on 5,6-dihydroxyindole-2-carboxylic acid (DHICA), a crucial intermediate in the eumelanin biosynthetic pathway. As a peptide-based research tool, it is designed to model a specific functional region within the oxidase enzyme, enabling detailed investigations into the structure-function relationships, substrate recognition, and catalytic mechanisms relevant to melanin formation. The unique sequence of this peptide allows for targeted studies of protein-protein interactions, enzyme kinetics, and the modulation of oxidative processes associated with melanogenesis and related biochemical pathways.

Enzyme Mechanism Studies: Researchers utilize this peptide fragment to dissect the active site dynamics and substrate specificity of DHICA oxidase. By isolating the 277-297 region, scientists can investigate how this segment contributes to the overall catalytic activity and electron transfer processes inherent to the enzyme. Such studies are fundamental for elucidating the molecular determinants of oxidase function and for mapping the key residues involved in substrate binding and oxidation.

Peptide-Protein Interaction Analysis: The defined sequence of the 277-297 peptide serves as a valuable probe for examining intermolecular interactions between the oxidase and its natural partners or regulatory proteins. Using this fragment in binding assays, crosslinking experiments, or structural studies, researchers gain insight into how the enzyme's C-terminal region mediates associations that influence melanin synthesis and cellular localization. These findings are instrumental in characterizing the regulatory networks governing pigment biosynthesis.

Antibody Generation and Epitope Mapping: The synthetic peptide is frequently employed as an immunogen for the production of sequence-specific antibodies targeting the oxidase's 277-297 domain. Such antibodies are critical for immunodetection, Western blotting, immunoprecipitation, and localization studies, facilitating the identification and quantification of the oxidase in complex biological samples. Additionally, the peptide is used in epitope mapping to define antibody binding sites, thereby advancing the development of precise immunological tools for pigment cell biology.

Structure-Activity Relationship (SAR) Investigations: Incorporating the 277-297 peptide into SAR studies allows scientists to systematically modify individual amino acids and assess the impact on enzymatic function or protein interactions. These experiments provide a detailed understanding of the contribution of specific residues to the oxidase's activity, stability, and substrate affinity. Such insights are invaluable for rational design efforts aimed at modulating enzyme function or developing peptide-based inhibitors.

Peptide Synthesis and Analytical Method Development: The well-defined sequence and biochemical relevance of this peptide make it a standard reference for optimizing solid-phase peptide synthesis protocols and validating analytical techniques such as HPLC, mass spectrometry, or capillary electrophoresis. By serving as a model substrate or calibration standard, the peptide supports method development and quality control in peptide chemistry laboratories, ensuring robust and reproducible research outcomes.

1. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII